14
Participants
Start Date
February 29, 2008
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
Pazopanib (GW786034)
Pazopanib monotherapy
GSK Investigational Site, Buffalo
GSK Investigational Site, Sayre
GSK Investigational Site, Philadelphia
GSK Investigational Site, Newport News
GSK Investigational Site, Orlando
GSK Investigational Site, Fort Myers
GSK Investigational Site, Columbus
GSK Investigational Site, Duluth
GSK Investigational Site, Baton Rouge
GSK Investigational Site, Tulsa
GSK Investigational Site, Scottsdale
GSK Investigational Site, Seattle
GSK Investigational Site, Corpus Christi
Lead Sponsor
GlaxoSmithKline
INDUSTRY